Canfu Tuodu Jiaonang (参附脱毒胶囊)参附脱毒胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 成都芝芝药业有限公司Chinese legal name: 成都芝芝药业有限公司
主要成分Active Ingredients
- 制附子Zhifu Zi
- 人工牛黄Rengong Niuhuang
- 洋金花Yangjin Hua
- 钩藤Gou Teng
- 珍珠Zhen Zhu
- 人参ginseng
- 郁金Yu Jin
- 芦荟Lu Hui
- 甘草licorice
药物知识说明
制附子是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：人参ginseng、人工牛黄Rengong Niuhuang、制附子Zhifu Zi、洋金花Yangjin Hua、珍珠Zhen Zhu。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：人参-fa0b10ac成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 参附脱毒胶囊) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 人参ginseng, 人工牛黄Rengong Niuhuang, 制附子Zhifu Zi, 洋金花Yangjin Hua, 珍珠Zhen Zhu.
Explore other medicines containing the same ingredient: 人参 productsginseng products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 参附脱毒胶囊Recorded Chinese name: 参附脱毒胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.4g*24粒0.4 g × 24 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 成都芝芝药业有限公司Chinese legal name: 成都芝芝药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20020071
关联实体Relationships
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20020071
Manufacturer
Chinese legal name: 成都芝芝药业有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.4 g × 24 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字Z20020071
生产企业
成都芝芝药业有限公司(国产)
功能主治
温阳益气，清心凉肝。用于阿片类成瘾的急性戒断症状属脾肾阳虚，心肝热盛者。
用法用量
口服，一次3粒，一日3次；3?5日后酌情减至一次2粒，一日3次，或晚睡前3粒。
不良反应
1.服用者可出现口干、思睡、头晕头痛、视物模糊、萎靡、周身无力、步态不稳、晕厥、排尿困难、食欲不振、恶心呕吐、便秘、腹泻、尿频、瘙痒等；|2.少数患者用药后可出现肝功能异常；|3.偶见室性早搏。
禁忌
1.心脏病、严重消化系统疾病、青光眼、前列腺肥大患者禁用。|2.妊娠及哺乳期妇女禁用。
注意事项
1.本品处方使用了洋金花，含有莨菪碱类物质，应严格掌握剂量和疗程，需在医生指导下使用；|2.与催眠镇静药、镇痛药有协同作用，合用时应减量；|3.妊娠及哺乳期妇女禁用；|4.肝功、肾功能损害及治疗前舒张压低于7kPa者慎用；|5.使用者应注意监测肝功能。
贮藏
密封，置阴凉处。
规格
0.4g*24粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.